Hikal Ltd. (HIKAL) Share Price Rises 11.52% as Stock Trades at Rs 247.80

Hikal Share Price is trading at Rs 247.80, up 11.52% from the previous close, with market capitalisation at Rs 2,739.74 Cr. The move puts Hikal Ltd. share price in focus across Hikal Share Price Today, Hikal Stock News and Hikal Share Price News searches. According to latest Univest data, the session has delivered a clear share price rise, but the figures do not establish a company-specific catalyst. That makes the current Hikal Share Price move relevant mainly as a market event: investors are watching how the stock reacts around the day’s high, how turnover is shaping sentiment and whether the latest Hikal Stock News keeps attention anchored on valuation and sector context. For readers following Hikal Share Price Today, the key question is not just why the stock is rising, but what the latest numbers say about business quality, pricing in the healthcare space and how far the move fits into broader Indian stock market trends.

Hikal Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 247.8
Previous Close	Rs 222.2
Today's Move	Rs 25.6 (+11.52%)
Open	Rs 224
High	Rs 249
Low	Rs 218.7
Turnover	Rs 2.76 crore
Market Capitalisation	Rs 2,739.74 crore
Market Cap Category	Small Cap

Hikal Ltd. (HIKAL) rose to Rs 247.8 from the previous close of Rs 222.2, a move of Rs 25.6 or 11.52%. The stock opened at Rs 224, reached a high of Rs 249, recorded a low of Rs 218.7.

Hikal Share Price Today shows a firm intraday gain, with the stock opening at Rs 224, touching a high of Rs 249 and a low of Rs 218.7 before last trading at Rs 247.80. The move of Rs 25.6 over the previous close of Rs 222.2 highlights strong price action in Hikal Stock News today, while turnover stood at Rs 2.76 Cr. In simple terms, the share price rise has carried Hikal close to the day’s upper band, which is why the stock is appearing in Stocks in News and among Top Gainers Today on the Share Market Today screen. For traders scanning Hikal Share Price Live, the latest session confirms active interest, even though the available numbers do not identify a single trigger behind the rise.

Hikal Ltd. (HIKAL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,739.74 crore
P/B Ratio	2.3x
ROE	7.41%
ROCE	9.88%
EPS	Rs -2.74
Book Value Per Share	Rs 96.62
Dividend Yield	0.27%

Hikal Ltd. (HIKAL) fundamental metrics show P/B 2.3x, ROE 7.41%, ROCE 9.88%. These figures provide context only and are not a buy or sell signal.

Hikal Ltd. has a market capitalisation of Rs 2739.74 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 2.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.41% and ROCE of 9.88%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -2.74, book value per share of Rs 96.62, dividend yield of 0.27%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	2.3x
Benchmark Median P/B	2.92x
Company ROE	7.41%
Benchmark Median ROE	11.78%
Company ROCE	9.88%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 2,739.74 crore
Benchmark Median Market Cap	Rs 674.09 crore

Hikal Ltd. (HIKAL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Hikal Ltd. (HIKAL) has a ROE of 7.41%, which is below the benchmark median of 11.78%, a difference of -37.1%. Hikal Ltd. (HIKAL) has a ROCE of 9.88%, which is below the benchmark median of 13.65%, a difference of -27.62%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

Its ROE of 7.41% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 9.88% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Hikal Ltd. (HIKAL) has a market capitalisation of Rs 2,739.74 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Hikal

• Hikal Share Price rose 11.52% to Rs 247.80, making it one of the more notable stocks rising today in Healthcare.
• The stock traded between Rs 218.7 and Rs 249, which keeps Hikal Share Price Today near the intraday upper end.
• Hikal Market Cap of Rs 2,739.74 Cr gives the move enough scale to matter in Hikal Stock News and Market Movers screens.
• P/B of 2.3 sits below the same-industry median, so valuation remains part of the Hikal Fundamental Analysis discussion.
• ROE of 7.41% and ROCE of 9.88% trail the industry medians, keeping financial quality in focus for Univest readers.

About Hikal

Hikal Ltd. operates in the Pharmaceuticals & Drugs industry under the Healthcare sector. The company is followed in Hikal NSE and Hikal BSE searches because it belongs to a business set where investors track formulation, ingredient and healthcare-linked performance through the broader company overview lens. For readers scanning Hikal Company News, the main point is that the business sits inside a sector where market cap, valuation and capital efficiency are compared closely with peers. Hikal Share Price Today therefore reflects not only market sentiment but also how investors read the company’s position within the industry benchmark. Univest tracks such names because company-level price action, sector standing and financial ratios often move together in stock updates. For anyone checking Hikal Share Price, the stock remains a useful example of how a mid-sized healthcare company can attract attention on the back of sharp intraday price action even without a stated company-specific catalyst.

Frequently Asked Questions

Why is Hikal Share Price rising today?

Ans. Hikal Share Price is rising today because the stock is up 11.52% and last traded at Rs 247.80. The numbers confirm a strong price move, but they do not establish a company-specific catalyst.

What is Hikal Share Price Today?

Ans. Hikal Share Price Today is Rs 247.80, compared with the previous close of Rs 222.2. That means the stock is trading Rs 25.6 higher in the current session.

How much did Hikal stock gain today?

Ans. Hikal stock gained 11.52% today. The move took the share price from the previous close of Rs 222.2 to Rs 247.80, placing it among the more active healthcare names.

What is Hikal’s market capitalisation?

Ans. Hikal’s market capitalisation is Rs 2,739.74 Cr. That makes it a mid-sized company in the Pharmaceuticals & Drugs industry, above the industry median market cap in the same benchmark set.

Is Hikal expensive compared with peers?

Ans. Hikal’s P/B ratio of 2.3 is below the industry median of 2.92 and below several large peers. Its ROE and ROCE also trail stronger-return names, so valuation looks restrained rather than stretched.

What do Hikal EPS and book value show?

Ans. Hikal’s EPS is -2.74, while book value is Rs 96.62. EPS reflects earnings attributable to each share, and book value shows accounting net worth per share.

What does Hikal dividend yield indicate?

Ans. Hikal’s dividend yield is 0.27%. Dividend yield reflects the historical payout relative to the current price, so it helps investors compare income contribution with valuation and price movement.

How does Hikal compare with other healthcare peers?

Ans. Compared with peers such as Sun Pharma, Cipla and Zydus Lifesciences, Hikal is much smaller in market cap and has lower ROE and ROCE. That puts today’s Hikal Share Price rise in a different valuation bracket.

Track Hikal Share Price on Univest

Use Hikal Ltd. (HIKAL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Hikal Share Price on Univest for live price updates, market cap, valuation ratios, financial ratios and sector context. The platform also helps users follow Hikal Share Price Today alongside broader Hikal Stock News, Hikal Latest News and Hikal Stock Performance coverage in one place.